MedPath

Randomized comparison of two contemporary balloon devices in catheter ablation of atrial fibrillation - Cryoballoon versus Laserballon II

Not Applicable
Conditions
I48.0
I48.1
Paroxysmal atrial fibrillation
Persistent atrial fibrillation
Registration Number
DRKS00012423
Lead Sponsor
CCB Cardioangiologisches Centrum Bethanien, Markus Krankenhaus
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Paroxysmal and persistent atrial fibrillation with an episode duration of > 7 days and < 1 year or patients with electrical cardioversion > 48 h after atrial fibrillation episode onset
- Ineffective treatment with at least one antiarrhythmic drug (class I-III) or betablocker
- Age 18 - 80 years
- Left atrial size < 45 mm
- Left ventricular ejection fraction > 45 %
- Patient is able to provide informed consent

Exclusion Criteria

- Contraindications for pulmonary vein isolation
- Previous pulmonary vein isolation attempts
- Inability to be treated with oral anticoagulation
- Presence of intracardiac thrombi
- Pregnancy
- Participation in other clinical studies
- Mitral regurgitation = III°
- Moderate mitral stenosis
- Unwilling to follow the study protocol and to attend follow-up visits

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Documented (ECG and CRF (90-days-, 180-days-, 360-days-Follow Up)) recurrence of atrial fibrillation or any atrial tachyarrhythmia lasting > 30 seconds between day 90 and 365 after the index procedure.
Secondary Outcome Measures
NameTimeMethod
- Incidence of peri-procedural complications such as: major bleeding requiring intervention, phrenic nerve palsy, pericardial tamponade, thromboembolic events, death<br>- Number of gaps in the ablation line during the repeat procedure<br>- Multiple procedure success rate
© Copyright 2025. All Rights Reserved by MedPath